ID   C1QBP_RAT               Reviewed;         279 AA.
AC   O35796; Q6IRS5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 157.
DE   RecName: Full=Complement component 1 Q subcomponent-binding protein, mitochondrial;
DE   AltName: Full=GC1q-R protein;
DE   AltName: Full=Glycoprotein gC1qBP;
DE            Short=C1qBP;
DE   Flags: Precursor;
GN   Name=C1qbp; Synonyms=Gc1qbp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9414106; DOI=10.1016/s0014-5793(97)01348-3;
RA   Lynch N.J., Reid K.B., van den Berg R.H., Daha M.R., Leigh L.A.,
RA   Ghebrehiwet B., Lim W.B., Schwaeble W.J.;
RT   "Characterisation of the rat and mouse homologues of gC1qBP, a 33 kDa
RT   glycoprotein that binds to the globular 'heads' of C1q.";
RL   FEBS Lett. 418:111-114(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 205-217, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [4]
RP   INTERACTION WITH VGF.
RX   PubMed=24106277; DOI=10.1074/jbc.m113.510917;
RA   Chen Y.C., Pristera A., Ayub M., Swanwick R.S., Karu K., Hamada Y.,
RA   Rice A.S., Okuse K.;
RT   "Identification of a receptor for neuropeptide VGF and its role in
RT   neuropathic pain.";
RL   J. Biol. Chem. 288:34638-34646(2013).
CC   -!- FUNCTION: Multifunctional and multicompartmental protein involved in
CC       inflammation and infection processes, ribosome biogenesis, protein
CC       synthesis in mitochondria, regulation of apoptosis, transcriptional
CC       regulation and pre-mRNA splicing. At the cell surface is thought to act
CC       as an endothelial receptor for plasma proteins of the complement and
CC       kallikrein-kinin cascades. Putative receptor for C1q; specifically
CC       binds to the globular 'heads' of C1q thus inhibiting C1; may perform
CC       the receptor function through a complex with C1qR/CD93. In complex with
CC       cytokeratin-1/KRT1 is a high affinity receptor for kininogen-1/HMWK.
CC       Can also bind other plasma proteins, such as coagulation factor XII
CC       leading to its autoactivation. May function to bind initially fluid
CC       kininogen-1 to the cell membrane. The secreted form may enhance both
CC       extrinsic and intrinsic coagulation pathways. It is postulated that the
CC       cell surface form requires docking with transmembrane proteins for
CC       downstream signaling which might be specific for a cell-type or
CC       response. By acting as C1q receptor is involved in chemotaxis of
CC       immature dendritic cells and neutrophils and is proposed to signal
CC       through CD209/DC-SIGN on immature dendritic cells, through integrin
CC       alpha-4/beta-1 during trophoblast invasion of the decidua, and through
CC       integrin beta-1 during endothelial cell adhesion and spreading.
CC       Signaling involved in inhibition of innate immune response is
CC       implicating the PI3K-AKT/PKB pathway. Required for protein synthesis in
CC       mitochondria (By similarity). In mitochondrial translation may be
CC       involved in formation of functional 55S mitoribosomes; the function
CC       seems to involve its RNA-binding activity. May be involved in the
CC       nucleolar ribosome maturation process; the function may involve the
CC       exchange of FBL for RRP1 in the association with pre-ribosome particles
CC       (By similarity). Involved in regulation of RNA splicing by inhibiting
CC       the RNA-binding capacity of SRSF1 and its phosphorylation (By
CC       similarity). Is required for the nuclear translocation of splicing
CC       factor U2AF1L4 (By similarity). Involved in regulation of CDKN2A- and
CC       HRK-mediated apoptosis. Stabilizes mitochondrial CDKN2A isoform smARF.
CC       May be involved in regulation of FOXC1 transcriptional activity and
CC       NFY/CCAAT-binding factor complex-mediated transcription. May play a
CC       role in antibacterial defense as it can bind to cell surface hyaluronan
CC       and inhibit Streptococcus pneumoniae hyaluronate lyase. May be involved
CC       in modulation of the immune response; ligation by HCV core protein is
CC       resulting in suppression of interleukin-12 production in monocyte-
CC       derived dendritic cells. Involved in regulation of antiviral response
CC       by inhibiting RIGI- and IFIH1-mediated signaling pathways probably
CC       involving its association with MAVS after viral infection. Acts as a
CC       regulator of DNA repair via homologous recombination by inhibiting the
CC       activity of MRE11: interacts with unphosphorylated MRE11 and RAD50 in
CC       absence of DNA damage, preventing formation and activity of the MRN
CC       complex. Following DNA damage, dissociates from phosphorylated MRE11,
CC       allowing formation of the MRN complex (By similarity).
CC       {ECO:0000250|UniProtKB:O35658, ECO:0000250|UniProtKB:Q07021}.
CC   -!- SUBUNIT: Homotrimer; three monomers form a donut-shaped structure with
CC       an unusually asymmetric charge distribution on the surface. Interacts
CC       with CDK13, HRK, VTN, NFYB, ADRA1B, FOXC1, DDX21, DDX50, NCL, SRSF1 and
CC       SRSF9. Interacts with CD93; the association may represent a cell
CC       surface C1q receptor. Interacts with KRT1; the association represents a
CC       cell surface kininogen receptor. Interacts with CD209; the interaction
CC       is indicative for a C1q:C1QBP:CD209 signaling complex. Interacts with
CC       FBL and RRP1; the respective interactions with C1QBP are competitive.
CC       Probably associates with the mitoribosome. Interacts with MAVS; the
CC       interaction occurs upon viral transfection. Interacts with PPIF.
CC       Interacts with U2AF1L4. Interacts with PLEKHN1. Interacts with VGF-
CC       derived peptide TLQP-21 (PubMed:24106277). Interacts with MRE11 and
CC       RAD50; forming the MRC (MRE11-RAD50-C1QBP) complex that inhibits the
CC       activity of MRE11 (By similarity). {ECO:0000250|UniProtKB:O35658,
CC       ECO:0000250|UniProtKB:Q07021, ECO:0000269|PubMed:24106277}.
CC   -!- INTERACTION:
CC       O35796; P18841: ADRA1B; Xeno; NbExp=5; IntAct=EBI-915544, EBI-6391008;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q07021}. Nucleus {ECO:0000250|UniProtKB:Q07021}.
CC       Cell membrane {ECO:0000250|UniProtKB:Q07021}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:Q07021}; Extracellular side
CC       {ECO:0000250|UniProtKB:Q07021}. Secreted
CC       {ECO:0000250|UniProtKB:Q07021}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q07021}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q07021}. Note=Seems to be predominantly
CC       localized to mitochondria. Secreted by activated lymphocytes.
CC       {ECO:0000250|UniProtKB:Q07021}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9414106}.
CC   -!- SIMILARITY: Belongs to the MAM33 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001102; CAA04531.1; -; mRNA.
DR   EMBL; BC070510; AAH70510.1; -; mRNA.
DR   RefSeq; NP_062132.2; NM_019259.2.
DR   AlphaFoldDB; O35796; -.
DR   SMR; O35796; -.
DR   BioGRID; 248302; 4.
DR   IntAct; O35796; 10.
DR   MINT; O35796; -.
DR   STRING; 10116.ENSRNOP00000031020; -.
DR   GlyGen; O35796; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O35796; -.
DR   PhosphoSitePlus; O35796; -.
DR   jPOST; O35796; -.
DR   PaxDb; 10116-ENSRNOP00000031020; -.
DR   Ensembl; ENSRNOT00055056157; ENSRNOP00055046310; ENSRNOG00055032503.
DR   Ensembl; ENSRNOT00060044097; ENSRNOP00060036581; ENSRNOG00060025453.
DR   Ensembl; ENSRNOT00065051325; ENSRNOP00065042262; ENSRNOG00065029716.
DR   GeneID; 29681; -.
DR   KEGG; rno:29681; -.
DR   UCSC; RGD:2230; rat.
DR   AGR; RGD:2230; -.
DR   CTD; 708; -.
DR   RGD; 2230; C1qbp.
DR   VEuPathDB; HostDB:ENSRNOG00000006949; -.
DR   eggNOG; KOG4024; Eukaryota.
DR   HOGENOM; CLU_083914_0_0_1; -.
DR   InParanoid; O35796; -.
DR   OrthoDB; 2912795at2759; -.
DR   PhylomeDB; O35796; -.
DR   TreeFam; TF315160; -.
DR   Reactome; R-RNO-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   PRO; PR:O35796; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000006949; Expressed in ovary and 20 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005759; C:mitochondrial matrix; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:SynGO.
DR   GO; GO:0031690; F:adrenergic receptor binding; IDA:UniProtKB.
DR   GO; GO:0001849; F:complement component C1q complex binding; IDA:RGD.
DR   GO; GO:0060703; F:deoxyribonuclease inhibitor activity; ISO:RGD.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0005540; F:hyaluronic acid binding; ISS:UniProtKB.
DR   GO; GO:0030984; F:kininogen binding; ISS:UniProtKB.
DR   GO; GO:0097177; F:mitochondrial ribosome binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IDA:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0042256; P:cytosolic ribosome assembly; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; TAS:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; ISS:UniProtKB.
DR   GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; ISS:UniProtKB.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; ISS:UniProtKB.
DR   GO; GO:0039534; P:negative regulation of MDA-5 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0039536; P:negative regulation of RIG-I signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0070131; P:positive regulation of mitochondrial translation; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:1901165; P:positive regulation of trophoblast cell migration; ISS:UniProtKB.
DR   GO; GO:0030449; P:regulation of complement activation; ISS:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   Gene3D; 3.10.280.10; Mitochondrial glycoprotein; 1.
DR   InterPro; IPR003428; MAM33.
DR   InterPro; IPR036561; MAM33_sf.
DR   PANTHER; PTHR10826; COMPLEMENT COMPONENT 1; 1.
DR   PANTHER; PTHR10826:SF1; COMPLEMENT COMPONENT 1 Q SUBCOMPONENT-BINDING PROTEIN, MITOCHONDRIAL; 1.
DR   Pfam; PF02330; MAM33; 1.
DR   SUPFAM; SSF54529; Mitochondrial glycoprotein MAM33-like; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Adaptive immunity; Apoptosis; Cell membrane;
KW   Complement pathway; Cytoplasm; Direct protein sequencing; DNA damage;
KW   Immunity; Innate immunity; Membrane; Mitochondrion; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome;
KW   Ribosome biogenesis; Secreted; Transcription; Transcription regulation;
KW   Transit peptide.
FT   TRANSIT         1..71
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           72..279
FT                   /note="Complement component 1 Q subcomponent-binding
FT                   protein, mitochondrial"
FT                   /id="PRO_0000018592"
FT   REGION          74..91
FT                   /note="C1q binding"
FT                   /evidence="ECO:0000250"
FT   REGION          134..162
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          166..210
FT                   /note="Interaction with MAVS"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         92
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35658"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         198
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07021"
FT   CONFLICT        63..64
FT                   /note="VP -> GS (in Ref. 1; CAA04531)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        68..70
FT                   /note="GCG -> AA (in Ref. 1; CAA04531)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="W -> G (in Ref. 1; CAA04531)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        193
FT                   /note="E -> Q (in Ref. 1; CAA04531)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   279 AA;  30997 MW;  54D238EFBCA6F41B CRC64;
     MLPLLRCVPR ALGAAATGLR ASIPAPPLRH LLQPAPRPCL RPFGLLSVRA GSARRSGLLQ
     PPVPCACGCG ALHTEGDKAF VEFLTDEIKE EKKIQKHKSL PKMSGDWELE VNGTEAKLLR
     KVAGEKITVT FNINNSIPPT FDGEEEPSQG QKAEEQEPEL TSTPNFVVEV TKTDGKKTLV
     LDCHYPEDEI GHEDEAESDI FSIKEVSFQT TGDSEWRDTN YTLNTDSLDW ALYDHLMDFL
     ADRGVDNTFA DELVELSTAL EHQEYITFLE DLKSFVKSQ
//
